Ajinomoto Co. is a global manufacturer of high-quality seasonings, processed foods, beverages, amino acids, pharmaceuticals and specialty chemicals. For many decades Ajinomoto Co. has contributed to food culture and human health through wide-ranging application of amino acid technologies. Today, the company is becoming increasingly involved with solutions for improved food resources, human health and global sustainability. Founded in 1909 and now operating in 26 countries, Ajinomoto Co. had net sales of JPY 1,197.3 billion (USD 15.1 billion) in fiscal 2011. The Ajinomoto Group Standards of Business Conduct (hereinafter the "Standards of Conduct") describe the conduct that every member of the Ajinomoto Group must understand and practice every day in order to implement the Ajinomoto Group Philosophy in accordance with the Ajinomoto Group Way. The Standards of Conduct also represent the commitments made to all stakeholders by Ajinomoto Group companies. Ajinomoto aim to be "a group of companies that contributes to human health globally" by continually creating unique value to benefit customers. To become a global group of food companies centered on the world's No. 1 seasoning business. To become a global group of aminoscience companies that contributes to humankind with the world's No. 1 amino acid technology. To become a group of health-promoting companies with a scientific approach to good taste and health.

Part of Arkema SA, Arkema France SA is a company headquartered in Colombes, France, that manufactures and supplies vinyl products, industrial chemicals and performance products. Thierry le Hénaff is the CEO, in this role since 2004.

Qingdao Yuanzhilin Agricultural Technology Development Co., Ltd., established on 2014-07-01, The business scope includes agricultural products,feed,pesticide,fertilizer,Healthy food,traditional Chinese medicine,Research and development of crop seed technology(Does not include production). (Items subject to approval by law,Business activities can only be carried out after approval by relevant departments).

Martek Biosciences provides nutritional products that promote health and wellness. It engages in developing products related to infant nutrition, child and adult nutrition, prenatal nutrition, animal nutrition, and sports nutrition. Its product line catering to prenatal nutrition is focused on products for pregnant and nursing women. Animal nutrition products of Martek Biosciences cater to the segments of companion animals, equine, livestock, and aquaculture requirements. Martek Biosciences also provides various consumer health and wellness products. Its products are inclusive of a long-chain polyunsaturated omega-6 fatty acid for infant brain development and physical growth; and a vegetarian source of docosahexaenoic acid for brain, eye, and heart health development. Its products are distributed through its worldwide network of distributors and mass, club, drug, grocery, and specialty stores. Martek Biosciences was established in 1985, headquartered in Columbia, Maryland. It operates manufacturing, and research and development facilities in Colorado, South Carolina, Connecticut, and Kentucky. It currently operates as a subsidiary of Royal DSM N.V.

Degussa AG is the world's third largest producer of precious metals. The company operates three divisions; precious metals and banking, which is involved in precious metals trading, production of precious metals and the manufacture of precious metal compounds and products in addition to operating its own bank, 'Degussa Bank', which is a universal bank providing traditional banking services. Chemical products is the second division and is involved in manufacturing fine and special chemicals, rubbers, pigments and chemical catalysts. The third and final division, health and nutrition is involved in manufacturing pharmaceuticals, dental chemicals and fodder additives. The company has subsidiaries in Germany, other European countries, USA, Brazil, Singapore, Japan and South Korea.

Enzon Pharmaceuticals, Inc. is a biopharmaceutical company dedicated to the development, manufacturing, and commercialization of important medicines for patients with cancer and other life-threatening conditions. Enzon has a portfolio of four marketed products, ONCASPAR®, DEPOCYT®, ABELCET® and ADAGEN®. The Company's drug development programs utilize several cutting-edge approaches, including its industry-leading PEGylation technology platform used to create product candidates with benefits such as reduced dosing frequency and less toxicity. Enzon's PEGylation technology was used to develop two of its products, ONCASPAR and ADAGEN, and has created a royalty revenue stream from licensing partnerships for other products developed using the technology. Enzon also engages in contract manufacturing for several pharmaceutical companies to broaden the Company's revenue base.

Sichuan China Tobacco Industry Co., Ltd., established on 2006-09-22, Business scope includes cigarettes,Cigar production and sales;tobacco leaf,cut tobacco,Purchase of recured tobacco leaves;cigarette paper,filter stick,Purchase of tobacco tow;Purchase of Tobacco Special Machinery(The above items and deadlines are subject to the permit).(The following scope does not include pre-licensed items,Post-licensing projects operate on the basis of licenses or approval documents)Import and export business;Investment and Asset Management(Do not engage in illegal fundraising,Financial activities such as absorbing public funds).(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)

Jiangsu New Hanling Bioengineering Co., Ltd., established on 2002-07-15, Business scope includes bioengineering technology research and development,technology transfer;amino acid(cystine,Leucine,Tyrosine),Compound Amino Acid Manufacturing,Sales;Amino Acid Derivatives Sales;organic fertilizer,compound fertilizer,blended fertilizer,organic-Inorganic Compound Fertilizer,Compound amino acid powder fertilizer,water soluble fertilizer,Page fat production,Sales;Self-operated and agent import and export business of various commodities and technologies.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments) licensed items:Food additive production;pharmaceutical production(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments,Specific business projects are subject to approval results) General project:Food Additive Sales(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license)

The Group's principal activity is to produce pharmaceuticals and chemicals. The operations are carried out through the following divisions: Pharmaceuticals; Bio chemical; Chemicals; Food and Other. Pharmaceuticals include ethical drugs, bulk pharmaceuticals and biological research. Bio chemicals deal with biochemical diagnostic reagents, animal health products, agrochemicals and fertilizers. Chemicals includes solvents, plasticizes and their raw materials, detergent raw materials and specialty chemicals. Food includes alcoholic beverages, alcohol, seasonings, confectionery, baking ingredients and processed foods. Others include wholesale, commodity distribution and installation of facilities.

Otsuka Holdings operates in pharmaceuticals, nutraceuticals, and consumer products. The business activity of the company includes providing healthcare solutions in the areas of the nervous system, oncology, cardiovascular system, respiratory system, infectious disease, and others. The company engages in the research and development of functional foods and beverages, such as electrolyte drinks, nutritional foods, soy snacks, and dietary foods.

Jiangsu Jinwei Ammonia Biological Engineering Co., Ltd., established on 2013-04-19, Business scope includes technical research and development of bioengineering;Healthy food(soft capsule,hard capsule,tablet,powder,Granules,pill)production and sales of;engaged in food(candy,Tea(kind)drinks,protein drink,solid drink,other drinks,monosodium glutamate,seasoning)production;Pre-packaged food(Does not contain refrigerated frozen food),bulk food(Does not contain refrigerated frozen food)promotion of;Biological product(Does not contain dangerous goods)research and development,Sales;Self-operated and agent import and export business of various commodities and technologies(Except for commodities and technologies that the state restricts enterprises to operate or prohibits import and export);road general cargo transportation;Own house rental.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments) licensed items:Catering Services;Tobacco retail(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments,Specific business projects are subject to approval results) General project:Wedding etiquette service;Etiquette service;Organize cultural and artistic exchange activities;food delivery service;Catering Management;Conference and Exhibition Services;property management;Corporate Image Planning;marketing planning;Professional cleaning,to clean,Disinfection service;building cleaning service;Household Appliances Repair;Urban Greening Management;Housekeeping;car park service(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license)

Pripps Bryggerier AB, a subsidiary of Carlsberg A/S, is a company headquartered in Stockholm, Sweden, specializing in malt beverages.

Otsuka Pharmaceutical Factory, Inc. manufactures and distributes pharmaceutical and nutritional products. Its products include medical foods, hine E-gel, processlead, engelead, innerpower, oronine h ointment, urepearl plus lotion 10 and urepearl plus cream. The company was founded on September 1, 1921 and is headquartered in Naruto, Japan.

Manufactures and sells pharmaceuticals

Ningbo Yuanfa Biological Engineering Co., Ltd., established on 2003-12-04, Business scope includes licensed projects:Food additive production(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments,Specific business projects are subject to approval results).General project:Food Additive Sales;Feed Additive Sales;Sales of bio-based materials;Chemical product sales(No licensed chemical products);Research and development of bio-based materials technology;R&D of industrial enzyme preparations;Research and development of bio-based material polymerization technology;Bio-feed R&D;Manufacturing of plastic products;Sales of plastic products;Technical Services,technology development,technical consulting,Technology Exchange,technology transfer,Technology Promotion;Engineering and Technology Research and Experimental Development;Standardized service;Food import and export;Import and export agency;Technology Import and Export;Import and export(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license).

Unilever Plc engages in the manufacture and sale of consumer goods. It operates through the following segments: Beauty & Wellbeing, Personal Care, Home Care, Nutrition, and Ice Cream. The Beauty & Wellbeing segment offers hair care, skin care, and prestige beauty and health & wellbeing. The Personal Care segment consists of sales of skin cleansing, deodorant, and oral care products. The Home Care segment comprises of sales of fabric care and a wide range of cleaning products. The Nutrition segment refers to sales of scratch cooking aids, dressings, and tea products. The Ice Cream segment covers primarily ice cream products. The company was founded by Antonius Johannes Jurgens, Samuel van den Bergh, and William Hulme Lever on January 1, 1930 and is headquartered in London, the United Kingdom.

Mitsubishi Tanabe Pharma contribute to the healthier lives of people around the world through the creation of pharmaceuticals. Mitsubishi Tanabe Pharma contribute to the healthier lives of people around the world through the creation of pharmaceuticals.” In accordance with this philosophy, as we implement our business activities we strive to realize our vision, which expresses that “Mitsubishi Tanabe Pharma strive to be a global research-driven pharmaceutical company that is trusted by communities.” As a company that is trusted and highly evaluated by patients and health care professionals as well as by society and shareholders, we will implement management with a focus on transparency and fairness while always keeping in mind the starting point of our business activities: “Everything we do is for the patients.”

Samsung Engineering Co., Ltd. engages in the provision of engineering, construction, and project management services. It operates through the Chemical Engineering and Non-Chemical Engineering business divisions. The Chemical Engineering division provides petropolitics, gas, upstream, and others. The Non-Chemical Engineering division offers infrastructure, plants, water treatment construction, and others. The company was founded on January 20, 1970 and is headquartered in Seoul, South Korea.